| Pharmaceutical active ingredients: |
| ChlorthalidoneDihydroergocristine MesylateReserpine |
| Available forms, composition and doses of Neocrystepin: |
| N / A |
| Neocrystepin medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C02LA51 - Reserpine and diuretics, combinations with other drugsC04AE54 - Dihydroergocristine, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Zentiva |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Clorpres | Chlorthalidone; Clonidine Hydrochloride | Mylan; Bertek Pharmaceuticals |
| Clothalton | Chlorthalidone; Clonidine Hydrochloride | Sarabhai Piramal Pharma |
| Combipres | Chlorthalidone; Clonidine Hydrochloride | Boehringer Ingelheim |
| Combipresan | Chlorthalidone; Clonidine Hydrochloride | Boehringer Ingelheim |
| Trimecryton | Chlorthalidone; Dihydroergocristine Mesylate; Metipranolol | Zentiva |
| Impresso | Chlorthalidone; Hydralazine Hydrochloride; Oxprenolol Hydrochloride | Alpharma |
| Impresso-Puren | Chlorthalidone; Hydralazine Hydrochloride; Oxprenolol Hydrochloride | Alpharma |
| Trepress | Chlorthalidone; Hydralazine Hydrochloride; Oxprenolol Hydrochloride | Novartis; Azupharma; Sandoz |
| Biotens | Chlorthalidone; Labetalol Hydrochloride | Kemyos Biomedical Research |
| Diurolab | Chlorthalidone; Labetalol Hydrochloride | Leben's |